Navigation Links
Catalyst Pharmaceutical Partners Selected to Present at Epilepsy Conference Highlighting New and Promising Therapies
Date:2/17/2010

CORAL GABLES, Fla., Feb. 17 /PRNewswire/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) announced today that it was selected by both the Scientific and Business Advisory Boards of the Epilepsy Therapy Project to present at the 2010 Epilepsy Pipeline Update Conference, an in-depth, two day forum to be held February 25-26, 2010, at the Hyatt Embarcadero Hotel in San Francisco.  Charles W. Gorodetzky, M.D., Ph.D., Catalyst's Chief Medical Officer will present an overview of CPP-115, Catalyst's development stage anticonvulsant compound, as a potential treatment for a variety of epileptic conditions, including complex partial seizures and infantile spasms (West Syndrome).

"We are pleased to be invited to join such a prestigious roster of speakers," stated Dr. Gorodetzky.  "With the acquisition of worldwide rights to CPP-115, Catalyst will enter the epilepsy therapy arena with a very promising drug candidate. This meeting is an ideal venue to introduce our new compound.  Catalyst will present its initial development plans and explain why we believe this drug may have improved safety and efficacy characteristics compared with the current GABA aminotransferase inhibitor, Sabril®, to an audience of experts in the development and marketing of new and existing epilepsy therapies.  Catalyst looks forward to introducing this new compound as well as receiving valuable comments from these experts."

"CPP-115 works through the same mechanism of action as Sabril®, the marketed version of vigabatrin, which was recently approved by the FDA and is known to be an effective anti-epileptic. Compared to other anti-epileptics, CPP-115 could have a relatively benign neuro
'/>"/>

SOURCE Catalyst Pharmaceutical Partners, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. IDEXX Laboratories Announces Catalyst Dx(R) Placement Total for 2009 and Installed Base of SmartService(TM) Customers
2. Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results
3. Catalyst Pharmaceutical Partners, Inc. Announces Organizational Changes and Extension of Chief Executives Employment Agreement
4. Catalyst Pharmaceutical Partners, Inc. Announces the Closing of $3.97 Million Registered Direct Offering
5. Sigma-Aldrich(R) Partners With Flow Chemistry Leader ThalesNano to Provide CatCart(R) Catalyst Products for Rapidly Growing Market
6. Catalyst Pharmaceutical Partners, Inc. To Raise $3.97 Million In Registered Direct Offering
7. Catalyst Pharmaceutical Partners Continues Clinical Development of CPP-109 For The Treatment of Cocaine and Methamphetamine Addiction
8. Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction
9. Catalyst Reaches Enrollment Target for its U.S. Phase II Cocaine Trial
10. Catalyst Pharmaceutical Partners Announces Publication of Animal Data Demonstrating Vigabatrin Effective for Weight Loss
11. Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... Diabetes Care®, Inc. (NASDAQ: TNDM ), a medical ... Pumps, today announced the closing of its previously announced underwritten ... price to the public of $11.50 per share, which includes ... to purchase up to an additional 787,500 shares. All of ... BofA Merrill Lynch and Piper Jaffray ...
(Date:3/4/2015)... March 4, 2015  Nevro Corp. (NYSE: ... and commercialized an innovative, evidence-based neuromodulation platform for the ... release financial results for the fourth quarter  and full ... 18, 2015. Company management will host a conference call ... Time) on Wednesday, March 18, 2015. ...
(Date:3/4/2015)... 4, 2015  Mail-service and specialty pharmacies will ... and government health plans $11.8 billion over the ... Pharmaceutical Care Management Association (PCMA). "Home ... of the easiest ways to reduce health costs," ... . "Policymakers should resist efforts to restrict these ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Closing of Underwritten Public Offering of Common Stock 2PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Illinois Employers, Consumers and Public Programs by $11.8 Billion 2
(Date:3/5/2015)... In recognition of its ongoing commitment ... Flordis International (SFI) has been honored by the American ... natural medicine company committed to identifying and developing natural ... and effectiveness. For these efforts the non-profit ABC selected ... in Phytomedicinal Research Award. , Phytomedicinal research seeks ...
(Date:3/5/2015)... Building on its commitment to provide oncology ... Academy of Oncology Nurse & Patient Navigators (AONN+) has ... ™ (CONQUER ™). , “Cancer has become ... their loved ones each year,” says Pam Rattananont Ferris, ... there is a need in the oncology space for ...
(Date:3/5/2015)... Hinton, W.Va. (PRWEB) March 05, 2015 ... looming, but rather here—and it’s a crisis that is ... , In order to stay on top of ... are partnering with PracticeLink to meet face-to-face with physicians ... Career Advancement Workshop and Job Fair series. , Physician ...
(Date:3/4/2015)... UK (PRWEB) March 05, 2015 ... clinical therapeutics landscape over the past decade. The ... carriers for drug delivery in the form of ... delivering manifold drugs with more safety and efficiency. ... nanoparticles could perhaps rely greatly upon the enhanced ...
(Date:3/4/2015)... (PRWEB) March 05, 2015 The ... a value of $5,632.8 million by 2019, at ... of 2014 to 2019. , Browse through the ... analysis of industry trends and segments, with the ... , Phthalic Anhydride (PA) is a derivative ...
Breaking Medicine News(10 mins):Health News:SFI Receives Prestigious ABC’s Tyler Award Given For Global Research Effort 2Health News:SFI Receives Prestigious ABC’s Tyler Award Given For Global Research Effort 3Health News:The Academy of Oncology Nurse & Patient Navigators Launches CONQUER: the patient voice™ to Help Meet the Informational Needs of Patients with Cancer 2Health News:Physician Shortage Crisis Worsening 2Health News:Cancer Nanomedicine Marketplace Discussed by Kuick Research in Topical Study Recently Published at MarketPublishers.com 2Health News:Cancer Nanomedicine Marketplace Discussed by Kuick Research in Topical Study Recently Published at MarketPublishers.com 3Health News:The Asia-Pacific Ohthalic Anhydride Market is Estimated to Reach $5,632.8 Million by 2019 - A Report by MicroMarket Monitor 2Health News:The Asia-Pacific Ohthalic Anhydride Market is Estimated to Reach $5,632.8 Million by 2019 - A Report by MicroMarket Monitor 3
... of California, Los Angeles say that certain compounds found in ... The scientists found that two compounds found in plant roots ... is responsible for tooth decay. ,This plant root ... study are to appear in the Feb. 24 print version ...
... of life of patients suffering from Motor Neurone Disease (MND), ... use of a simple ventilator and facemask//. ,Patients ... new technique called non-invasive ventilation (NIV). It works by helping ... muscles, the online edition of BBC News reported. ...
... company, Schering, has obtained promising results in the development ... contraceptive, which comes almost 45 years after Schering developed ... in the form of an implanted hormonal capsule and ... project is headed by a slightly-built 53-year-old woman, Professor ...
... 250,000 early-stage glaucoma patients risk blindness due to lack of ... National Institute for the Blind (RNIB).// In an attempt to ... has been launched in the UK. ,Apart from ... from some form of visual impairment in the UK. The ...
... drugs which were found to be an effective anti-depressant ... the researchers are not sure about the mechanism of ... ,Assistant Professor Gerard Aherm and team from Georgetown University ... Inhibitors) which has been found to be an effective ...
... from Northwestern University, Feinberg School of Medicine have found ... to inhibit the production of the immune cells Cytokines ... for causing inflammation in brain cells leading to neuron ... disease. ,Alzheimer’s disease is characterized by loss ...
Cached Medicine News:Health News:Male Contraceptive Pill Being Developed By Berlin Pharmaceutical 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: